Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  OptimizeRx Corporation    OPRX

OPTIMIZERX CORPORATION

(OPRX)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news

OPTIMIZERX CORP : Other Events, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/12/2019 | 08:33am EDT
Item 8.01 Other Events



On February 11, 2019, we issued a press release announcing our findings from a physician survey focused on prescription drug costs. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information in Item 8.01 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits

99.1 Press release, dated February 11, 2019

                                       1

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on OPTIMIZERX CORPORATION
04/24OPTIMIZERX : to Present at Investor Conferences in May
AQ
04/23OPTIMIZERX CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
04/23OPTIMIZERX : to Present at Investor Conferences in May
AQ
04/08OPTIMIZERX CORP : Other Events (form 8-K)
AQ
04/08OptimizeRx Expands Investment in Hospitals and Health Systems with Latest Tec..
GL
03/21OPTIMIZERX CORP : Other Events (form 8-K)
AQ
03/20OptimizeRx Survey Shows Providers Want to Engage with Patients on Drug Costs ..
GL
03/12OPTIMIZERX : Management's Discussion and Analysis of Financial Condition and Res..
AQ
03/04OPTIMIZERX CORP : Other Events (form 8-K)
AQ
03/04OptimizeRx to Present at the 31st Annual ROTH Conference on March 17-19, 2019..
GL
More news
Financials ($)
Sales 2019 28,4 M
EBIT 2019 1,36 M
Net income 2019 1,30 M
Debt 2019 -
Yield 2019 -
P/E ratio 2019 113,68
P/E ratio 2020 38,12
Capi. / Sales 2019 4,60x
Capi. / Sales 2020 3,62x
Capitalization 131 M
Chart OPTIMIZERX CORPORATION
Duration : Period :
OptimizeRx Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPTIMIZERX CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 23,9 $
Spread / Average Target 121%
EPS Revisions
Managers
NameTitle
William J. Febbo Chief Executive Officer & Director
Miriam J. Paramore President
Gus D. Halas Chairman
Douglas Paul Baker CFO & Principal Accounting Officer
James D. Lang Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
OPTIMIZERX CORPORATION-1.55%131
JOHNSON & JOHNSON7.87%371 856
ROCHE HOLDING LTD.8.67%223 303
PFIZER-9.26%219 907
NOVARTIS10.35%204 940
MERCK AND COMPANY-0.09%197 192